Latest topics page 51
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 51 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Cold packs, phase-change material, and what survives ten days — does this still hold?
Asking directly, because I could not find a straight answer: Cold packs, phase-change material, and what survives ten days — does this still hold? A logistics question, since the answers here are usually…
|
2 | 22k | 22mo | |
|
Hoarding and why it makes a shortage worse
Posting this under the heading it deserves: Hoarding and why it makes a shortage worse Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
|
2 | 12k | 22mo | |
|
Revisiting: US compounding rules and how they changed
On the subject in the title: Revisiting: US compounding rules and how they changed Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As…
|
+5 | 9 | 26k | 23mo |
|
How to ask for a dose change without antagonising anyone
The question in the title: How to ask for a dose change without antagonising anyone I will give what I have already checked below so nobody repeats it. Asking about a population rather than about a person.…
|
+19 | 23 | 2.9k | 23mo |
|
[2026 update] People with a low starting BMI: where the evidence stops
People with a low starting BMI: where the evidence stops Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
|
+19 | 23 | 62k | 23mo |
|
A rising related-substance total over six months: degradation or method drift?
Asking directly, because I could not find a straight answer: A rising related-substance total over six months: degradation or method drift? Posting the method first, because I know what the first three…
|
+37 | 42 | 37k | 23mo |
|
Orforglipron as a non-peptide: what changes when the molecule is small
On the subject in the title: Orforglipron as a non-peptide: what changes when the molecule is small Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURMOUNT-4 ( JAMA ,…
|
+26 | 30 | 26k | 23mo |
|
Reading a meta-analysis you disagree with, fairly
Posting this under the heading it deserves: Reading a meta-analysis you disagree with, fairly Everything below is what sits behind that. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in support of a…
|
+7 | 13 | 2.5k | 23mo |
|
Circumference measurements as a poor man's composition estimate
Posting this under the heading it deserves: Circumference measurements as a poor man's composition estimate Everything below is what sits behind that. Longitudinal report with the method stated, because a…
|
+96 | 112 | 14k | 23mo |
|
Correlation in a self-tracked dataset: what it can support
Correlation in a self-tracked dataset: what it can support — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support of a claim I do not think it…
|
+152 | 166 | 48k | 23mo |
|
Follow-up: A partial dose because the pen emptied mid-injection
Posting this under the heading it deserves: A partial dose because the pen emptied mid-injection Everything below is what sits behind that. I have read the maintained page on this and I still have a gap, so I…
|
+10 | 14 | 10k | 23mo |
|
Chronic kidney disease and the FLOW result
Posting this under the heading it deserves: Chronic kidney disease and the FLOW result Everything below is what sits behind that. General question, not a request for advice about my own care — I know the…
|
+34 | 38 | 33k | 23mo |
|
High-resolution MS on aggregates and what it can see — one year on
High-resolution MS on aggregates and what it can see — one year on Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like…
|
+54 | 58 | 1.2k | 23mo |
|
Coming back to: Purity assay versus content assay: two different numbers
Purity assay versus content assay: two different numbers — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it anywhere. A…
|
+71 | 77 | 31k | 23mo |
|
The most common factual error about semaglutide on the internet
On the subject in the title: The most common factual error about semaglutide on the internet Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before posting; the…
|
2 | 49k | 2y | |
|
Coming back to: Pricing far outside the range, in either direction
Pricing far outside the range, in either direction Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the format the…
|
+22 | 26 | 325 | 2y |
|
Naming conventions for research peptides and the confusion they cause — one year on
Naming conventions for research peptides and the confusion they cause — one year on — setting out what I have, and where I think it stops being reliable. I have seen SURMOUNT-2 ( Lancet , 2023) cited in…
|
+1 | 5 | 181 | 2y |
|
[2026 update] Request: show the solution author in the topic list
Request: show the solution author in the topic list Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the documentation commons. The…
|
2 | 59 | 2y | |
|
Mean kinetic temperature explained without the mathematics
Posting this under the heading it deserves: Mean kinetic temperature explained without the mathematics Everything below is what sits behind that. Practical question with the units stated, because I have seen…
|
2 | 1.5k | 2y | |
|
The mass-error checker and its intended scope
The mass-error checker and its intended scope Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would like it checked.…
|
+149 | 167 | 42k | 2y |
|
Second pass at: Journal club: LEADER as the historical anchor
Posting this under the heading it deserves: Second pass at: Journal club: LEADER as the historical anchor Everything below is what sits behind that. Comparing SCALE ( N Engl J Med , 2015) with SURPASS-2 ( N…
|
+75 | 81 | 2k | 2y |
|
Guidelines revision: what changed and why
Guidelines revision: what changed and why Writing it up because I had to work it out twice and would rather nobody else did. Process question about how this site works. I have read the guidelines and the…
|
+127 | 142 | 1.7k | 2y |
|
How this community labels and discusses unrefereed work
How this community labels and discusses unrefereed work — that is the question, and I have not found it answered plainly anywhere I have looked. I have seen SCALE ( N Engl J Med , 2015) cited in support of a…
|
+112 | 119 | 1.3k | 2y |
|
Follow-up: Conditions that change the calculus rather than forbidding it
Posting this under the heading it deserves: Conditions that change the calculus rather than forbidding it Everything below is what sits behind that. General question, not a request for advice about my own…
|
+30 | 34 | 62k | 2y |
|
Where the four-week escalation interval comes from, and what it is not
On the subject in the title: Where the four-week escalation interval comes from, and what it is not Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I…
|
+56 | 60 | 21k | 2y |
|
Refrigerated versus room temperature: the trade-off stated plainly
Refrigerated versus room temperature: the trade-off stated plainly Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have…
|
2 | 66k | 2y | |
|
Second pass at: Retatrutide dose escalation in the published trials
Second pass at: Retatrutide dose escalation in the published trials — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim…
|
+115 | 125 | 30k | 2y |
|
Cold packs, phase-change material, and what survives ten days
Cold packs, phase-change material, and what survives ten days — setting out what I have, and where I think it stops being reliable. A logistics question, since the answers here are usually better than…
|
+132 | 138 | 65k | 2y |
|
Oral contraceptives and delayed emptying: what the data shows
Posting this under the heading it deserves: Oral contraceptives and delayed emptying: what the data shows Everything below is what sits behind that. Reporting something rather than asking about it, in case…
|
+63 | 71 | 5.9k | 2y |
|
Journal club: FLOW and the renal composite, component by component
On the subject in the title: Journal club: FLOW and the renal composite, component by component Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before posting;…
|
+84 | 91 | 18k | 2y |